Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
Selective inhibition of CDK9 in triple negative breast cancer.
Mustafa EH, Laven-Law G, Kikhtyak Z, Nguyen V, Ali S, Pace AA, Iggo R, Kebede A, Noll B, Wang S, Winter JM, Dwyer AR, Tilley WD, Hickey TE
Oncogene. 2023 Nov 24. doi: 10.1038/s41388-023-02892-3. PubMed Article

Plasmids from Article

ID Plasmid Purpose
174720pDRM98 mKate2 BlastExpresses the NLS-tagged mKate2 gene, P2A and the blasticidin resistance gene.
174721pDRM18 LTN (Luciferase tdTomato Neo)Expresses the firefly luciferase gene, E2A, tdTomato, P2A, and the neomycin resistance gene.
174722pDRM210 LGP (Luciferase GFP Puro)Expresses the firefly luciferase gene, E2A, eGFP, F2A, and the puromycin resistance gene
174723pDRM209 LTP (Luciferase tdTomato Puro)Expresses the firefly luciferase gene, E2A, tdTomato, T2A, and the puromycin resistance gene.
183502pDRM166 LKB (Luciferase mKate2 Blast)Expresses the firefly luciferase gene, the NLS-tagged mKate2 gene, and the blasticidin resistance gene joined by P2A linkers.

Antibodies from Article